The 36-month beta value for COCH is also noteworthy at 2.57. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for COCH is 6.14M, and at present, short sellers hold a 0.50% of that float. The average trading volume of COCH on May 07, 2024 was 442.62K shares.
COCH) stock’s latest price update
The stock price of Envoy Medical Inc (NASDAQ: COCH) has dropped by -20.92 compared to previous close of 4.35. Despite this, the company has seen a fall of -29.94% in its stock price over the last five trading days. Newsfile Corp reported 2024-01-30 that White Bear Lake, Minnesota–(Newsfile Corp. – January 30, 2024) – Envoy Medical®, Inc. (NASDAQ: COCH) (“Envoy Medical”), a revolutionary hearing health company focused on fully implanted hearing systems, will be participating in The Microcap Conference, which will take place January 30, 31, February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ. Brent Lucas, Chief Executive Officer, will be presenting on January 31 & February 1, 2024.
COCH’s Market Performance
Envoy Medical Inc (COCH) has seen a -29.94% fall in stock performance for the week, with a -44.16% decline in the past month and a 138.06% surge in the past quarter. The volatility ratio for the week is 17.46%, and the volatility levels for the past 30 days are at 14.39% for COCH. The simple moving average for the past 20 days is -35.41% for COCH’s stock, with a -27.46% simple moving average for the past 200 days.
COCH Trading at -34.22% from the 50-Day Moving Average
After a stumble in the market that brought COCH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.65% of loss for the given period.
Volatility was left at 14.39%, however, over the last 30 days, the volatility rate increased by 17.46%, as shares sank -46.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +173.02% upper at present.
During the last 5 trading sessions, COCH fell by -29.94%, which changed the moving average for the period of 200-days by -66.07% in comparison to the 20-day moving average, which settled at $5.18. In addition, Envoy Medical Inc saw 89.99% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COCH starting from Lucas Brent T., who purchase 12,380 shares at the price of $0.97 back on Nov 21 ’23. After this action, Lucas Brent T. now owns 120,831 shares of Envoy Medical Inc, valued at $11,990 using the latest closing price.
Stock Fundamentals for COCH
Current profitability levels for the company are sitting at:
- -54.09 for the present operating margin
- -2.47 for the gross margin
The net margin for Envoy Medical Inc stands at -50.15. The total capital return value is set at -17.02. Equity return is now at value -1.82, with -1.71 for asset returns.
Based on Envoy Medical Inc (COCH), the company’s capital structure generated -0.47 points at debt to capital in total, while cash flow to debt ratio is standing at -23.96.
Currently, EBITDA for the company is -18.24 million with net debt to EBITDA at 0.21. When we switch over and look at the enterprise to sales, we see a ratio of 201.8. The receivables turnover for the company is 1.28for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.03.
Conclusion
In summary, Envoy Medical Inc (COCH) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
